Navigation Links
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy
Date:11/25/2013

ditional objectives include the exploration of anti-tumor and biomarker responses to allow dose determination and potential patient stratification in subsequent studies. The trial will enroll patients at four locations in the United States.

"In addition to its potential in cancer, recombinant IL-10 has demonstrated anti-inflammatory and anti-fibrotic activities as well as cholesterol lowering abilities in preclinical disease models and in human subjects," commented Carl L. Gordon, Ph.D., C.F.A., partner and co-head of global private equity at OrbiMed, and a member of the ARMO board of directors. "We believe that ARMO is ideally positioned to explore the unique mechanisms of action for this important immunotherapy compound, with possible breakthrough potential in several indications."

ARMO has over 45 issued and pending US and foreign patents and applications covering compositions of matter, methods of use, and methods of manufacturing of AM0010.

About ARMO BioSciences, Inc.

ARMO BioSciences is focused on developing immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis and inflammatory diseases. ARMO believes that by harnessing the body's own capability to arm itself against dysregulated cells, it may provide safer and more effective drugs for patients suffering from grievous diseases. ARMO's medicines are designed to normalize the underlying biology of disease through immunotherapeutic mechanisms for sustained and durable responses. Founded in 2012, ARMO is backed by investors Kleiner Perkins Caufield & Byers, OrbiMed and DAG Ventures. 

About Kleiner Perkins Caufield & Byers

Kleiner Perkins Caufield & Byers (KPCB) has backed entrepreneurs in more than 500 ventures leading to 150 IPOs, 350,000 jobs and a deep strategic network. The firm has helped build pioneering companies like Amazon, Electronic Arts, Genentech,
'/>"/>

SOURCE ARMO BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014   MedNet Solutions , a global ... is pleased to announce that it will once again be ... (SCDM) Annual Conference, to be held this year from September ... , Nevada. MedNet team members, in conjunction with representatives from many ... will also be in attendance, will be providing demonstrations of ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
(Date:9/23/2014)... Sept. 23, 2014  Hill-Rom (NYSE: HRC ... Health ( Renton, WA ), the nation,s ... the companies, existing relationship as Hill-Rom now becomes Providence ... capital bed frame and surface products. ... in the U.S.  It operates 34 hospitals, 475 physician ...
Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
... SILVER SPRING, Md., May 2, 2011 The U.S. ... used with diet and exercise, to improve blood glucose ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) People with Type ... insulin, a hormone that regulates the amount of glucose ...
... and SEATTLE, May 2, 2011 CMC Biologics, ... in Copenhagen, Denmark and Seattle, Washington USA, announced ... serve at its Chief Executive Officer. CMC Biologics, ... delivering  world class, fully integrated, biopharmaceutical process development ...
Cached Medicine Technology:FDA Approves New Treatment for Type 2 Diabetes 2CMC Biologics Announces Appointment of New CEO 2
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- ... (ADHD) also undergo behavioral therapy, and the rates ... a new study finds. Medication alone can ... some do better if they also receive behavioral ... The researchers analyzed data in more than 1,500 ...
(Date:9/23/2014)... obese as teenagers could grow up to earn up ... weight. So says Petter Lundborg of Lund University, Paul ... University and Lund University, all in Sweden. The team ... the United States, and the results are published in ... analyzed large-scale data of 145,193 Swedish-born brothers who enlisted ...
(Date:9/23/2014)... Vancouver Electrician Contractors, Pro Ace, has ... electrical services in Vancouver, BC. The company will provide ... a small maintenance project or a large-scale new installation ... meet the needs of the individual commercial client. Pro ... of an affordable price. As a result, businesses of ...
(Date:9/23/2014)... The Sloane Clinic™, a leading chain of ... advanced aesthetic dermatology and cosmetic solutions now adds ... care repertoire. Specially formulated with super-powered antioxidant Lipo-Fullerene ... forces of aging, acne and photo damage while ... is revolutionizing the way we treat and protect ...
(Date:9/23/2014)... 23, 2014 Risperdal lawsuits ( http://www.drugbot.com/risperdal/lawsuit/ ... country, Bernstein Liebhard LLP reports. According to an Order ... on September 19th, the Court has dismissed fraud and ... that jurisdiction on behalf of a man who allegedly ... to his use of Risperdal. In dismissing the Plaintiff’s ...
Breaking Medicine News(10 mins):Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... the risk of colon cancer. It is well known that ... the risk of cancer. Now researchers are beginning to find ... produce contain. //The latest report, from researchers at Hopkins University, ... risk of colon cancer. ,Groups of rats that ...
... new review of the medical proof, the drug pentoxifylline is ... ulcers are caused by poor circulation and they are quite ... by compression stretch bandages, but up to a third of ... treatment.// ,Doctors at the University of New Zealand, ...
... loss are going down well with those who use them. ... over 60 in the United States. Traditionally there was one ... hearing aid. // ,Now, however, there's another choice - ... surrounding bones. Researchers in the US have surveyed 100 adults ...
... has to be taken into consideration before deciding to ... acoustic swannoma) is a benign tumour affecting the eighth ... hearing and problems with balance.// Standard treatment is removal ... whether this is worthwhile in older people with limited ...
... a huge men population, which evaluated more than 14,000 sperm ... reducing their numbers as well as their crucial ability to ... as the ozone level went up, the sperm concentration went ... and obstetrics and gynecology at the University of Southern California's ...
... radiant-light therapy may be an effective treatment for depression ... of psychiatry at the Yale School of Medicine in ... potentially non-toxic antidepressant light therapy in pregnancy is a ... experiment to see whether exposure to bright light, a ...
Cached Medicine News:Health News:Elevated Ozone Levels Hurt Sperm Count 2
Standard knife with box, C profile...
... some sectioning work, it is necessary to cool ... Freezer can be fitted to most microtomes and ... or lower, depending on conditions. The equipment consists ... The cooling stage is best suited for operation ...
... Stages fit easily onto most microtomes. These ... only the AC supply and a trickle of ... immediately and can be maintained indefinitely. Stage ... can be set for different kinds of tissue. ...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum...
Medicine Products: